Sex Differences in the Effects of Etonogestrel on Respiratory Recovery in an In Vivo Rat Model of Central Chemoreflex Impairment
Acta Physiologica · 2026
DOI: 10.1111/apha.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2026. Verfasst von Silvia Cardani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Desogestrel, Chemoreceptor Cells, Respiration, Sleep Apnea, Central. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, CIHR, Organon Investigator-Initiated Study Program.
Abstract (Originalsprache)
Aim
Rhythmic breathing movements driven by the brainstem rely on chemosensory inputs to homeostatically adjust motor output to the prevailing metabolic demand. The central CO 2 chemoreflex is a critical component of this neural circuitry, as defects in these sensors cause hypoventilation syndromes, which are typically difficult to manage pharmacologically. Progesterone has long been known to stimulate breathing in both sexes, and remarkably the progestinic metabolite, etonogestrel (ETO), enhances CO 2 chemosensitivity in animal models and female patients affected by congenital central hypoventilation syndrome. However, ETO‘s mechanisms and sites of action remain unknown, and the experimental use of synthetic progestins has been met with mixed respiratory outcomes.
Methods
In our recent work, we demonstrated that chronic ETO treatment improved the CO 2 chemoreflex in female rats in which < 80% of chemoreceptor neurons comprising the retrotrapezoid nucleus (RTN) were eliminated. Since the progesterone receptor is widely expressed in both the male and female brain, we investigated whether ETO‐induced CO 2 chemoreflex recovery can be replicated in male rats in which RTN neurons are partially eliminated by the use of substance P‐saporin toxin.
Results
Our results confirm dose‐dependent impairment of the CO 2 chemoreflex in both sexes following chemoreceptor lesion and corroborate the findings that ETO treatment restores ventilation in female rats with moderate‐sized lesions. Interestingly, female respiratory recovery was associated with increased expression of the pH‐sensing genes Gpr4 and Task2 in the RTN.
Conclusion
In contrast, male rats failed to show significant recovery with ETO treatment, suggesting a sex‐specific mechanism through which ETO promotes CO 2 chemoreflex recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Women and Children's Health Research Institute, University of Alberta, Edmonton, Alberta, Canada.
- Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Tara A Janes, Silvia Pagliardini
Förderung
- NIH HHS
- CIHR
- Organon Investigator-Initiated Study Program
- Canadian Institute for Health Research (CIHR) Postdoctoral Fellowships
- Canadian Lung Association BaO Fellowship
- Oregon National Primate Research Center
- University of Alberta
- National Institutes of Health
Zitieren
APA
Cardani, S., Janes, T. A., Asif, R., & Pagliardini, S. (2026). Sex Differences in the Effects of Etonogestrel on Respiratory Recovery in an In Vivo Rat Model of Central Chemoreflex Impairment. Acta Physiologica. https://doi.org/10.1111/apha.70194
Vancouver
Cardani S, Janes TA, Asif R, Pagliardini S. Sex Differences in the Effects of Etonogestrel on Respiratory Recovery in an In Vivo Rat Model of Central Chemoreflex Impairment. Acta Physiologica. 2026. doi:10.1111/apha.70194
BibTeX
@article{Cardani2026,
author = {Cardani, Silvia and Janes, Tara A and Asif, Ryaad and Pagliardini, Silvia},
title = {Sex Differences in the Effects of Etonogestrel on Respiratory Recovery in an In Vivo Rat Model of Central Chemoreflex Impairment},
journal = {Acta Physiologica},
year = {2026},
doi = {10.1111/apha.70194}
}
EUVIMED